Overview
Location
South Korea, Seoul
Employees
11-50
Founded date
2019
Investors 3
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 6, 2025 | AJU IB Investment | ajuib.co.kr |
| Company K Partners | kpartners.co.kr |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 30, 2021 | A new prognostic method to fight the most dangerous cancer | Non-Small Cell Lung Cancer (NSCLC) accounts for approximately 25% of cancer deaths. A new method which Scailyte and Geninus develop in a collaboration will provide clinicians with tools for an informed therapeutic decision. |
| Mar 24, 2021 | Ocean Genomics Partners With Geninus to Co-Develop RNA-Based Biomarkers and Advance Research | PITTSBURGH--(BUSINESS WIRE)--Mar 24, 2021-- Ocean Genomics (Pittsburgh, PA), a world leader in AI-based gene expression analysis and RNA biomarker development, and Geninus (Seoul, South Korea), a leading full-service genomics laboratory, an... |
Reviews 0
FAQ about Geninus
When was Geninus founded?
Geninus was founded in 2019.
Who has invested in Geninus?
Parsers VC lists 3 investors of Geninus, among them AJU IB Investment and Company K Partners.
What has the press written about Geninus?
Parsers VC has collected 3 articles mentioning Geninus, among them “A new prognostic method to fight the most dangerous cancer” (Mar 30, 2021) and “Ocean Genomics Partners With Geninus to Co-Develop RNA-Based Biomarkers and Advance Research” (Mar 24, 2021).
Is Geninus still active?
Yes, Geninus is active; its latest activity on Parsers VC dates from Dec 6, 2025.